Changes in leadership for Alzheimer’s Research & Therapy
We are delighted to welcome Dr Philip Scheltens to his new position as one of the Editors-in-Chief of Alzheimer’s Research & Therapy, joining Dr Douglas Galasko (University of California, San Diego, USA) and Dr Todd Golde (University of Florida, USA). Dr Scheltens is replacing Dr Gordon Wilcock (University of Oxford, UK), who is stepping down from this role after many valuable years of guidance as Editor-in-Chief.
Dr Scheltens is Professor of Cognitive Neurology and Director of the Alzheimer Centre at the VU University Medical Centre in Amsterdam, which he founded in 2000. Dr Scheltens is active in the field of biomarkers and clinical trials, with his main clinical and research interests including Alzheimer’s disease, vascular dementia, frontotemporal dementia, …



